{"filing":{"accession_number":"0001493152-26-024884","cik":"0001878313","ticker":"MAIA","company_name":"MAIA Biotechnology, Inc.","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1878313/000149315226024884/form8-k.htm"},"events":[{"id":10667,"run_id":9355,"accession_number":"0001493152-26-024884","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from MAIA Biotechnology's 2026 Annual Meeting held on May 21, 2026, filed under Item 5.07. The filing reports voting outcomes for two proposals: (1) election of Class I directors (Louie Ngar Yee and Steven Chaouki re-elected) and (2) ratification of Grant Thornton LLP as independent auditor, with specific vote tallies for each matter. This is a routine but material governance disclosure required by Item 5.07.","company_name":"MAIA Biotechnology, Inc.","ticker":"MAIA","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":7041,"accession_number":"0001493152-26-024884","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from MAIA Biotechnology's 2026 Annual Meeting held on May 21, 2026, filed under Item 5.07. The filing reports voting outcomes for two proposals: (1) election of Class I directors (Louie Ngar Yee and Steven Chaouki re-elected) and (2) ratification of Grant Thornton LLP as independent auditor, with specific vote tallies for each matter. This is a routine but material governance disclosure required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:55:31.230442+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7041,"accession_number":"0001493152-26-024884","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from MAIA Biotechnology's 2026 Annual Meeting held on May 21, 2026, filed under Item 5.07. The filing reports voting outcomes for two proposals: (1) election of Class I directors (Louie Ngar Yee and Steven Chaouki re-elected) and (2) ratification of Grant Thornton LLP as independent auditor, with specific vote tallies for each matter. This is a routine but material governance disclosure required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:55:31.230442+00:00","company_name":"MAIA Biotechnology, Inc.","ticker":"MAIA","filing_date":"2026-05-22"}]}